NDC 0597-0035

SPEVIGO

Spesolimab-sbzo

SPEVIGO is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Spesolimab.

• Product ID: 0597-0035_d5c9f2bd-76f9-42f4-aa3c-1a20c6c313d6
• NDC: 0597-0035
• Product Type: Human Prescription Drug
• Proprietary Name: SPEVIGO
• Generic Name: Spesolimab-sbzo
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-09-01
• Marketing Category: BLA /
• Application Number: BLA761244
• Labeler Name: Boehringer Ingelheim Pharmaceuticals, Inc.
• Substance Name: SPESOLIMAB
• Active Ingredient Strength: 60 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0597-0035-10

2 VIAL, GLASS in 1 CARTON (0597-0035-10) > 7.5 mL in 1 VIAL, GLASS

• Marketing Start Date: 2022-09-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details